Richard Zelman MD

The field of cardiac cell therapy is rapidly evolving, with several ongoing clinical trials assessing the safety and efficacy of various cell-based approaches. Dr. Richard Zelman points to some of the most promising studies:   The C-CURE Trial: This trial investigated the use of cardiac progenitor cells in patients with chronic heart failure. Results showed that patients who received cell therapy experienced significant improvements in heart function and exercise capacity compared to those who received standard care.   The CHART-1 Trial: This trial evaluated the safety and efficacy of cardiopoietic stem cells in heart failure patients. Although the primary endpoint was not met, a subgroup analysis suggested potential benefits in specific patient populations, underscoring the need for more targeted approaches.   The DREAM-HF Trial: This ongoing study is exploring the use of mesenchymal precursor cells (MPCs) in patients with chronic heart failure. Dr. Zelman n...

Managing CHF requires a comprehensive approach that includes lifestyle modifications, medication, and, in some cases, surgical interventions. Dr. Richard Zelman stresses the importance of a personalized treatment plan tailored to the specific needs of each patient.   Lifestyle Modifications: Patients with CHF are often advised to adopt heart-healthy lifestyle changes to help manage their condition. This includes following a low-sodium diet to reduce fluid retention, engaging in regular, moderate exercise to strengthen the heart muscle, and avoiding alcohol and tobacco use. Weight management is also critical, as obesity can exacerbate heart failure symptoms.   Medication: Pharmacological treatment is a cornerstone of CHF management. Dr. Zelman often prescribes a combination of medications to help the heart work more efficiently and reduce symptoms. These may include ACE inhibitors or ARBs to relax blood vessels, beta-blockers to reduce the heart's workload, diuretics t...

  Congestive heart failure occurs when the heart muscle becomes weakened or stiff, leading to inadequate blood flow to meet the body's needs. The condition can result from various underlying causes, including coronary artery disease, hypertension, cardiomyopathy, and valvular heart disease. Over time, as the heart struggles to pump efficiently, fluid begins to accumulate in the lungs, abdomen, and extremities, leading to the hallmark symptoms of CHF: shortness of breath, fatigue, swelling in the legs and ankles, and persistent coughing or wheezing.   Richard Zelman MD emphasizes that CHF is not a single disease but a syndrome—a collection of symptoms that can arise from a variety of cardiac and non-cardiac conditions. This makes individualized treatment crucial, as the underlying cause of heart failure can vary widely from one patient to another.

  Congestive heart failure (CHF) is a chronic and progressive condition in which the heart's ability to pump blood effectively diminishes, leading to an array of symptoms that can significantly impact a person’s quality of life. Dr. Richard Zelman , a leading cardiologist, provides valuable insights into the management and treatment of this complex condition, emphasizing the importance of early detection, comprehensive treatment plans, and patient education.   Understanding Congestive Heart Failure Congestive heart failure occurs when the heart muscle becomes weakened or stiff, leading to inadequate blood flow to meet the body's needs. The condition can result from various underlying causes, including coronary artery disease, hypertension, cardiomyopathy, and valvular heart disease. Over time, as the heart struggles to pump efficiently, fluid begins to accumulate in the lungs, abdomen, and extremities, leading to the hallmark symptoms of CHF: shortness of breath, fatigue...

  Heart transplantation remains one of the most effective treatments for end-stage heart failure, a condition where the heart is no longer able to pump blood efficiently. However, a critical shortage of donor hearts limits the availability of this life-saving procedure, leaving many patients on long waiting lists. In response to this challenge, the medical community has been exploring alternative sources of donor hearts, including the use of genetically modified pig hearts  Dr. Richard Zelman , a leading cardiologist and researcher, has been actively involved in this groundbreaking area of xenotransplantation, which holds the potential to revolutionize heart transplantation and save countless lives.   The Promise of Xenotransplantation Xenotransplantation, the process of transplanting organs or tissues between different species, has long been a subject of scientific research. Pigs have emerged as the preferred source of organs for human transplantation due to their ...

  Richard Zelman MD is an esteemed Internist, Cardiologist and Interventional Cardiologist who has performed almost two thousand minimally invasive heart valve procedures, launched four cardiac catheterization laboratories, and successfully built the coalition that brought the very first community hospital open-heart cardiac surgical programs and coronary interventional programs to Massachusetts. He is considered one of the preeminent experts in his field of structural heart, interventional coronary and peripheral vascular catheter procedures. He is also extremely experienced in transthoracic and transesophageal echocardiography, nuclear cardiology, and implantable devices. Dr. Zelman is also a prolific clinical researcher and Primary Investigator, whose research has been published in numerous clinical journals, and was named one of America’s Top Doctors® by Castle Connolly Medical, Ltd.

  Dr. Richard Zelman , MD is an Internist in Hyannis, MA and has 41 years experience. They graduated from University of Texas Health Sciences Center at San Antonio Long School of Medicine. They currently practice at Ascension Medical Group Genesys Heart Center and are affiliated with Cape Cod Hospital. At present, Dr. Zelman received an average rating of 4.5/5 from patients and has been reviewed 11 times. Their office is not accepting new patients. Dr. Zelman is board certified in Cardiovascular Disease and accepts multiple insurance plans.